Nextage Therapeutics Ltd
Tel Aviv Stock Exchange NXTG.TA
Nextage Therapeutics Ltd Operating Income Margin for the year ending December 31, 2023: -455.14%
Nextage Therapeutics Ltd Operating Income Margin is -455.14% for the year ending December 31, 2023. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
-
Nextage Therapeutics Ltd Operating Income Margin for the year ending December 31, 2021 was -8,437.36%, a -2.12% change year over year.
-
Nextage Therapeutics Ltd Operating Income Margin for the year ending December 31, 2020 was -8,262.30%, a -457.20% change year over year.
-
Nextage Therapeutics Ltd Operating Income Margin for the year ending December 31, 2019 was -1,482.83%, a 43.49% change year over year.
Key data
| Date | Operating Income Margin | EBT Margin | Net Income Margin | EBITDA Margin |
|---|
Market news
Loading...
Tel Aviv Stock Exchange: NXTG.TA
| CEO | Mr. Abraham Dreazen |
| IPO Date | Aug. 12, 2002 |
| Location | Israel |
| Headquarters | Einstein St. Building 13B |
| Employees | 42 |
| Sector | Health Care |
| Industries | |
Description
Nextage Therapeutics Ltd develops cannabinoid-based products. The company is based in Ness Ziona, Israel.
Key trends
Past 5 years
StockViz Staff
January 16, 2025
Any question? Send us an email